Pituitary, Thyroid & Adrenal Disorders
From the Journals
Surgeon, primary care collaboration needed to catch hyperparathyroidism
Of 10,432 patients identified with hypercalcemia at the University of Alabama at Birmingham from 2011 to 2015, only 3,200 patients (31%) had a...
From the Journals
Sjögren’s syndrome most common extrahepatic PBC manifestation
Up to 73% of PBC patients also have Sjögren’s syndrome.
From the Journals
USPSTF: No thyroid cancer screening for asymptomatic adults
The harms of screening asymptomatic adults for thyroid cancer outweigh the benefits, according to the U.S. Preventive Services Task Force.
Conference Coverage
No increase in hand osteoarthritis seen in Sjögren’s syndrome
LAS VEGAS – But an unexpected link to hypothyroidism is found.
Conference Coverage
One in four practitioners doing FNAs are endocrinologists
Conference Coverage
Dulera inhaler linked to adrenocorticotropic suppression in small case series
ORLANDO – Why are some children with asthma short for their age? Maybe it’s their inhaler.
Conference Coverage
Osilodrostat maintained cortisol control in Cushing’s syndrome
ORLANDO – Osilodrostat controlled urinary-free cortisol consistently in patients with Cushing’s syndrome.
Conference Coverage
Long-acting growth hormone moves forward based on positive phase II data
An extended-release human growth hormone formulation offers a less-rigorous dosing schedule and potentially better patient compliance with...
From the Journals
Levothyroxine: No benefit for subclinical hypothyroidism in elderly
The lack of benefit extended across all older age groups, both genders, and all serum thyrotropin levels at baseline. Sensitivity analyses...
Conference Coverage
Temozolomide may help half of patients with aggressive pituitary tumors
Temozolomide, an alkylating agent approved for glioblastoma, improved long-term survival in about half of patients who took it for aggressive...
Conference Coverage
Thyroid cancer incidence: It’s not all good news
Despite a general upward trend over the past 3 decades, the incidence of thyroid cancer has dropped since 2010 in certain populations.